Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo
Abstract We aimed to identify potent biliverdin reductase (BVRA) inhibitors as a novel concept for the treatment of severe unconjugated hyperbilirubinemia. 1280 FDA-approved compounds were screened in vitro for their ability to inhibit human and rat BVRA activity and 26 compounds were identified a...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/d12f4548a8564f6a914ed21b89937903 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|